PA
FLNA

Perceptive Advisors’s Filana Therapeutics FLNA Stock Holding History

Perceptive Advisors’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-5,072
Closed -$194K – 138
2014
Q1 		$194K Hold
5,072
– – 0.02% 106
2013
Q4 		$172K Buy
+5,072
New +$135K 0.02% 90

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Perceptive Advisors's FLNA Position: Q2 2014 in Review

Perceptive Advisors sold out of Filana Therapeutics (FLNA) in Q2 2014, closing a stake of 5,072 shares — an estimated $194K sold.

Perceptive Advisors first reported a position in FLNA in Q4 2013 and held it in 2 quarters. The position peaked at $194K in Q1 2014. 87 funds tracked by Wall St. Rank hold FLNA as of Q2 2014.

  • Perceptive Advisors reported no remaining Filana Therapeutics position as of Q2 2014 after selling out during the quarter.
  • Perceptive Advisors sold 5,072 Filana Therapeutics shares in Q2 2014, an estimated $194K.
  • Perceptive Advisors first reported a position in Filana Therapeutics in Q4 2013 and held it in 2 quarters.
  • Perceptive Advisors's Filana Therapeutics position peaked at $194K in Q1 2014.
  • 87 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2014.

Based on Perceptive Advisors's 13F filing for Q2 2014, filed 14 Aug 2014.